Aclaris Therapeutics, Inc. financial data

Symbol
ACRS on Nasdaq
Location
Wayne, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 416% % -31%
Debt-to-equity 42% % 56%
Return On Equity -103% % -291%
Return On Assets -72% % -250%
Operating Margin -974% % -470%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108,345,239 shares 52%
Common Stock, Shares, Outstanding 108,342,592 shares 52%
Entity Public Float $76,100,000 USD -89%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 122,619,311 shares 72%
Weighted Average Number of Shares Outstanding, Diluted 122,619,311 shares 72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $15,741,000 USD -42%
Cost of Revenue $2,264,000 USD -19%
Research and Development Expense $45,087,000 USD -12%
General and Administrative Expense $21,350,000 USD -16%
Costs and Expenses $169,058,000 USD 130%
Operating Income (Loss) $153,317,000 USD -231%
Nonoperating Income (Expense) $11,637,000 USD -12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $141,680,000 USD -93%
Net Income (Loss) Attributable to Parent $141,680,000 USD -283%
Earnings Per Share, Basic -1 USD/shares -204%
Earnings Per Share, Diluted -1 USD/shares -204%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,256,000 USD -47%
Cash, Cash Equivalents, and Short-term Investments $167,200,000 USD -3.6%
Accounts Receivable, after Allowance for Credit Loss, Current $194,000 USD -40%
Assets, Current $100,592,000 USD -24%
Property, Plant and Equipment, Net $811,000 USD -28%
Other Assets, Noncurrent $2,834,000 USD -12%
Assets $175,534,000 USD -3.8%
Accounts Payable, Current $9,187,000 USD 20%
Employee-related Liabilities, Current $3,756,000 USD 44%
Accrued Liabilities, Current $9,784,000 USD 107%
Contract with Customer, Liability, Current $3,925,000 USD 4.2%
Liabilities, Current $25,631,000 USD 36%
Contract with Customer, Liability, Noncurrent $17,492,000 USD -17%
Operating Lease, Liability, Noncurrent $1,711,000 USD -24%
Other Liabilities, Noncurrent $1,711,000 USD -24%
Liabilities $55,434,000 USD 6.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $597,000 USD 40%
Retained Earnings (Accumulated Deficit) $947,989,000 USD -18%
Stockholders' Equity Attributable to Parent $120,100,000 USD -7.7%
Liabilities and Equity $175,534,000 USD -3.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,057,000 USD 37%
Net Cash Provided by (Used in) Financing Activities $275,000 USD
Net Cash Provided by (Used in) Investing Activities $19,119,000 USD 14%
Common Stock, Shares Authorized 400,000,000 shares 100%
Common Stock, Shares, Issued 108,342,592 shares 52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,787,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25,256,000 USD -47%
Deferred Tax Assets, Valuation Allowance $224,360,000 USD 15%
Deferred Tax Assets, Gross $225,516,000 USD 14%
Operating Lease, Liability $2,244,000 USD -17%
Depreciation $400,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $43,000 USD -68%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $141,510,000 USD -299%
Lessee, Operating Lease, Liability, to be Paid $3,235,000 USD -30%
Property, Plant and Equipment, Gross $5,795,000 USD -0.31%
Operating Lease, Liability, Current $533,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $742,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year One $694,000 USD -9.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $637,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $760,000 USD -12%
Deferred Tax Assets, Operating Loss Carryforwards $120,361,000 USD 1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $779,000 USD -12%
Additional Paid in Capital $1,067,491,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $128,000 USD -47%
Share-based Payment Arrangement, Expense $12,318,000 USD 33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%